BioPower Operations Corporation
BOPO · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 226.7% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $1 | $0 | -$0 | -$0 |
| Operating Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -103.5% | -163.6% | – | – |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$1 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -138.6% | -252.2% | – | – |
| EPS | -0.018 | -0.01 | -0.003 | -0.003 |
| % Growth | -75% | -233.3% | 0% | – |
| EPS Diluted | -0.018 | -0.01 | -0.003 | -0.003 |
| Weighted Avg Shares Out | 45 | 44 | 43 | 43 |
| Weighted Avg Shares Out Dil | 45 | 44 | 43 | 43 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 11.5% | 0% | – | – |